It's not too late: a proposal to standardize the terminology of “late-onset” cytomegalovirus infection and disease in solid organ transplant recipients-Reference-Cited by-同舟云学术

It's not too late: a proposal to standardize the terminology of “late-onset” cytomegalovirus infection and disease in solid organ transplant recipients

Published:2015-11-13 Issue:6 Volume:17 Page:779-784
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Razonable R.R.¹,Blumberg E.A.²

Affiliation:

1. Division of Infectious Diseases; Department of Medicine and the William J von Liebig Center for Transplantation and Clinical Regeneration; Mayo Clinic; Rochester Minnesota USA

2. Division of Infectious Diseases; Department of Medicine; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12447/fullpdf

Reference52 articles.

1. Cytomegalovirus in solid organ transplantation;Razonable;Am J Transplant,2013

2. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group;Lowance;N Engl J Med,1999

3. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected];Gane;Lancet,1997

4. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation;Merigan;N Engl J Med,1992

5. Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart-lung, and lung transplant recipients;Wreghitt;Transpl Int,1999

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Cost-effectiveness of Valganciclovir Prophylaxis Versus Preemptive Therapy in CMV R+ Kidney Transplant Recipients Over the First Year Posttransplantation;Transplantation Direct;2024-07-26

2. Pathogen-specific cell-mediated immunity to guide the management of cytomegalovirus in solid organ transplantation: state of the art clinical review;Expert Review of Clinical Immunology;2024-07-24

3. Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experience;European Journal of Haematology;2024-06-21

4. Prevention and management of cytomegalovirus infection and disease in kidney transplant: A consensus statement of the Transplantation Society of Taiwan;Journal of the Formosan Medical Association;2024-05

5. Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review;Expert Review of Anti-infective Therapy;2021-12-22